HIV-specific T cells can be generated against conserved non-escaped HIV epitopes for use in a phase I clinical trial: Pre-clinical validations and implications for a cure strategy for HIV
Cytotherapy(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要